Literature DB >> 32480243

Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.

Rohan Halder1, Tulika Seth2, Pradeep K Chaturvedi3, Priyanka Mishra2, Manoranjan Mahapatra2, Hara P Pati2, Seema Tyagi2, Renu Saxena2.   

Abstract

INTRODUCTION: Febrile neutropenia is a common cause in morbidity and mortality during treatment of hematological neoplasms.
METHODS: Subjects included all cases admitted under hematology department with febrile neutropenia from February to June 2018. Each febrile episode was investigated by standard investigations (Blood culture, Chest x ray etc.); Procalcitonin (PCT) and c reactive protein (CRP) was sent at fever onset 0, 24, 48 h, day 7 and day 14.
RESULTS: Data was analyzed for 52 febrile episodes in 50 patients. PCT cut off value at 24 h of ≤1.2 ng/ml had a sensitivity and specificity of 62.5% and 87.5% for discriminating Invasive fungal infection (IFI) and Microbiologically documented infection (MDI) (p = 0.033). PCT had a negative predictive value of 70% for the diagnosis of IFI as compared to MDI. CRP cut off >160 mg/dl at 48 h was suggestive of fever due to fungal infection with a sensitivity of 100%, specificity of 48%, PPV of 33.3% and NPV of 100%. CRP at 24 and 48 h of fever was useful to distinguish non-infectious causes of fever from infectious causes.
CONCLUSION: PCT at 24 h and CRP at 48 h was useful in identifying fungal infection. CRP was a better marker when compared to PCT for identifying disease fever.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C reactive protein; Febrile neutropenia; Invasive fungal infections; Procalcitonin

Mesh:

Substances:

Year:  2020        PMID: 32480243     DOI: 10.1016/j.bcmd.2020.102445

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  2 in total

1.  Label-free electrochemical biosensor for determination of procalcitonin based on graphene-wrapped Co nanoparticles encapsulated in carbon nanobrushes coupled with AuPtCu nanodendrites.

Authors:  Xin-Yue Ge; Jing-Xian Zhang; Yi-Ge Feng; Ai-Jun Wang; Li-Ping Mei; Jiu-Ju Feng
Journal:  Mikrochim Acta       Date:  2022-02-17       Impact factor: 5.833

2.  Diagnostic Value of Procalcitonin in Transplant Patients Receiving Immunosuppressant Drugs: A Retrospective Electronic Medical Record-Based Analysis.

Authors:  Hyojin Chae; Nicholas Bevins; Gregory B Seymann; Robert L Fitzgerald
Journal:  Am J Clin Pathol       Date:  2021-11-08       Impact factor: 5.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.